CYSTAGON (mercaptamine bitartrate)
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Cystagon
|
| Active substance |
mercaptamine bitartrate
|
| Therapeutic area (MeSH) |
Cystinosis
|
| Procedure number |
EMEA/H/C/000125
|
| DHPC type |
Quality defect
|
| Human ATC code |
A16AA04
|
| Dissemination date |
15/02/2023
|